Claude AI Says Market is Ignoring Ardelyx (ARDX) Growth Catalysts
Ardelyx, Inc (NASDAQ:ARDX) is a biotech company. It makes drugs for gut and kidney conditions.
Hedge Funds
News & Analysis
Top Fund Managers
Best Performing Funds
Featured Content
Insider Trading
News & Analysis
Latest Insider Purchases
Tang bought 50,945 Fulcrum Therapeutics Inc. shares at $3.52
Tang bought 116,671 Fulcrum Therapeutics Inc. shares at $3.56
Heinrich bought 4,608,575 Zerostack Corp. shares at $0.75
Titterton bought 12,000 Anixa Biosciences Inc shares at $3.47
Ra bought 7,882 Artiva Biotherapeutics Inc. shares at $8.95
Latest Insider Sales
Lally sold 1,525 Imagenebio Inc. shares at $5.34
Lally sold 1,671 Imagenebio Inc. shares at $5.50
Barrocas sold 250,000 Sharkninja Inc. shares at $155.01
Gupta sold 10 Synaptics Inc shares at $115.54
Gupta sold 350 Synaptics Inc shares at $114.76
Featured Content
Do not Miss

































